Michael Craig Pine

Insider Reports History

Entity
Individual
Location
C/O Eyepoint Pharmaceuticals, Inc., 480 Pleasant Street, Suite A 210, Watertown, MA
Signature
/s/ Ron Honig, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael Craig Pine:

Stock Role Class Num Shares Value Price $ Report Date Ownership
EyePoint Pharmaceuticals, Inc. Chief Corp Dev.&Strat. Officer Restricted Stock Units 30.6K $624K $20.40 Jan 6, 2024 Direct
EyePoint Pharmaceuticals, Inc. Chief Corp Dev.&Strat. Officer Common Stock 13.7K $342K $25.02 Jan 6, 2024 Direct
EyePoint Pharmaceuticals, Inc. Chief Corp Dev.&Strat. Officer Stock Option (Right to Buy) 42K Jan 5, 2024 Direct

Insider Reports Filed by Michael Craig Pine

Symbol Company Period Transactions Value $ Form Type Date Filed Role
EYPT EyePoint Pharmaceuticals, Inc. Jan 5, 2024 5 -$122K 4 Jan 9, 2024 Chief Corp Dev.&Strat. Officer
EYPT EyePoint Pharmaceuticals, Inc. Dec 4, 2023 4 -$443K 4/A Dec 11, 2023 Chief Corp Dev.&Strat. Officer
EYPT EyePoint Pharmaceuticals, Inc. Jun 20, 2023 1 $0 4 Jun 22, 2023 Chief Corp Dev.&Strat. Officer
EYPT EyePoint Pharmaceuticals, Inc. May 25, 2023 2 $0 4 May 30, 2023 Chief Corp Dev.&Strat. Officer
EYPT EyePoint Pharmaceuticals, Inc. Jan 6, 2023 1 $0 4 Jan 10, 2023 Chief Corp Dev.&Strat. Officer
EYPT EyePoint Pharmaceuticals, Inc. Mar 14, 2022 1 $12.2K 4 Mar 15, 2022 Chief Corp Dev.&Strat. Officer
EYPT EyePoint Pharmaceuticals, Inc. Jan 10, 2022 0 $0 3 Jan 14, 2022 Chief Corp Dev.&Strat. Officer
EYPT EyePoint Pharmaceuticals, Inc. Jan 10, 2022 1 $0 4 Jan 14, 2022 Chief Corp Dev.&Strat. Officer